Drugs / Endoxana
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00523159 | May 2007 → Aug 2009 | renal cell carcinoma | Immatics Biotechnologies GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Endoxana | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00523159 ↗ |
| Route | Intravenous | “a single i.v. infusion of Cyclophosphamid” NCT00523159 ↗ |